Pancreatic Cancer Pill Shows Promise in Clinical Study, Offering Hope for Indian Patients
A new drug targeting specific oncogenic RAS mutations has demonstrated extended survival for metastatic pancreatic cancer patients compared to chemotherapy in a recent study, a…
Read more